Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03386240 · ClinicalTrials.gov registry record · Phase 4
Antibacterial-coated Sutures at Time of Cesarean
A Phase 4 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1,169
- Enrollment target
NCT03386240 is a Phase 4 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 1,169 participants.
The verdict
NCT03386240, a Phase 4 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1,169 participants
- Enrollment target
Study Summary
Abdominal closure with antibacterial-coated sutures has been shown to reduce wound infections after a number of surgical procedures, but none of the previous trials included cesarean delivery. Our objective is to determine whether use of antibacterial-coated sutures reduces surgical site infection (SSI) after cesarean delivery.
Interventions
- DRUG Vicryl-plus, monocryl-plus, PDS-plus (Triclosan-coated Sutures)
- OTHER Vicryl, monocryl, PDS (not coated with triclosan)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,169 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2024-11-22 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03386240
The ClinicalTrials.gov registry entry for NCT03386240 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1,169 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vicryl-plus, monocryl-plus, PDS-plus (Triclosan-coated Sutures) is the first listed.
NCT03386240 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03386240 about?
NCT03386240 is a clinical study titled "Antibacterial-coated Sutures at Time of Cesarean". Abdominal closure with antibacterial-coated sutures has been shown to reduce wound infections after a number of surgical procedures, but none of the previous trials included cesarean delivery. Our objective is to determine whether use of antibacterial-coated sutures reduces surgical site infection (...
What is the current status of trial NCT03386240?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1,169 participants. The study started on 2018-01-09. Estimated completion is 2024-11-22.
What interventions are being tested in trial NCT03386240?
The interventions under investigation include: Vicryl-plus, monocryl-plus, PDS-plus (Triclosan-coated Sutures) (DRUG), Vicryl, monocryl, PDS (not coated with triclosan) (OTHER).
Who is sponsoring clinical trial NCT03386240?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.